Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity
Objectives. Oxidative stress contributes to Parkinson’s disease (PD) pathophysiology and progression. The objective was to describe central and peripheral metabolites of redox metabolism and to describe correlations between glutathione (Glu) status, age, and disease severity. Methods. 58 otherwise h...
Main Authors: | Laurie K. Mischley, Leanna J. Standish, Noel S. Weiss, Jeannie M. Padowski, Terrance J. Kavanagh, Collin C. White, Michael E. Rosenfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2016/9409363 |
Similar Items
-
Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity
by: Laurie K. Mischley, et al.
Published: (2017-06-01) -
Role of Diet and Nutritional Supplements in Parkinson’s Disease Progression
by: Laurie K. Mischley, et al.
Published: (2017-01-01) -
Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM Challenge
by: Solveig K. Sieberts, et al.
Published: (2021-03-01) -
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
by: Anna Santaella, et al.
Published: (2020-01-01) -
Synthesis of Glutathione-modified Protein-Based Nanocarriers for Treatment of Parkinson’s Disease
by: Yu-ChengTsai, et al.
Published: (2019)